Background Cardiovascular morbidity is high among patients with peripheral arterial
occlusive disease (PAOD). The aim of this study was to evaluate the ability of ischemia …

Objectives Albumin undergoes structural changes under ischemia and oxidative stress,
turning into ischemia-modified albumin (IMA). It has been proposed as an early biomarker …

Cardiovascular disease is the leading cause of mortality and morbidity in Western countries.
Despite its remarkable medical and social consequences, the prevalence of peripheral …

BACKGROUND: Ischemia modified albumin (IMA), is a new biomarker of oxidative
processes involved with coronary artery disease (CAD). We determined serum IMA, high …

The identification of circulating biomarkers of endothelial dysfunction (ED), a precursor to
atherosclerosis, in rheumatoid arthritis (RA) would facilitate early risk stratification and …

Objectives Ischemia-modified albumin (IMA), a new serum biomarker of myocardial
ischemia, has been introduced in the diagnosis of acute coronary syndrome. However, few …

Background: Ischemia-modified albumin (IMA) is a new marker of myocardial ischemia,
there is concern that IMA concentrations may be affected by ischemia occurring in tissues …

Background In this study, whether ischemia modified albumin (IMA) has a role in showing
severity or criticality of coronary arteries in patients with unstable angina pectoris …

Background Peripheral artery disease (PAD) becomes more prevalent with advancing age
and is associated with elevated risk of cardiovascular events and shortened life expectancy …

Objective To investigate the correlation between ischemia-modified albumin (IMA) levels
and coronary collateral circulation (CCC) in patients with chronic total occlusive (CTO) …